Source: International Congress 2014 – Roundtable discussion ‘Managing chronic P. aeruginosa infection’
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Roundtable discussion ‘Managing chronic P. aeruginosa infection’. International Congress 2014 – Roundtable discussion ‘Managing chronic P. aeruginosa infection’

Member's Comments

No comment yet.

Related content which might interest you: Roundtable discussion ‘Managing P. aeruginosa exacerbations’ Source: International Congress 2014 – Roundtable discussion ‘Managing P. aeruginosa exacerbations’ Year: 2014 Roundtable discussion ‘Managing P. aeruginosa at first isolation’ Source: International Congress 2014 – Roundtable discussion ‘Managing P. aeruginosa at first isolation’ Year: 2014 A comprehensive analysis of the impact of pseudomonas aeruginosa colonisation in adult bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 Interactive case study ‘Controversies in managing P. aeruginosa in non-CF bronchiectasis’ Source: International Congress 2014 – Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing Pseudomonas aeruginosa in non-CF Bronchiectasis’ – Full Video Year: 2014 Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing Pseudomonas aeruginosa in non-CF Bronchiectasis’ – Full Video Source: International Congress 2014 – Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing Pseudomonas aeruginosa in non-CF Bronchiectasis’ – Full Video Year: 2014 Pseudomonas aeruginosa colonisation in patients without bronchiectasis Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura Year: 2014 Pseudomonas aeruginosa pneumonia in the community Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Comparison between two protocols of preventing treatment of chronic Pseudomonas aeruginosa (Pa) infection Source: Eur Respir J 2005; 26: Suppl. 49, 620s Year: 2005 LATE-BREAKING ABSTRACT: Pseudomonas aeruginosa strain prevalence, adaptation and diversification, during chronic lung infections of UK non-cystic fibrosis bronchiectasis patients Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016 Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre Source: Eur Respir J 2006; 27: 937-943 Year: 2006 Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD. Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020 Pseudomonas aeruginosa infection and exacerbations in bronchiectasis: more questions than answers Source: Eur Respir J, 51 (2) 1702497; 10.1183/13993003.02497-2017 Year: 2018 Epidemiology of Pseudomonas aeruginosa in a cystic fibrosis rehabilitation centre Source: Eur Respir J 2005; 25: 474-481 Year: 2005 Pseudomonas aeruginosa eradication therapy on Cystic Fibrosis- Guideline and clinical routine Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018 The prevalence of antimicrobial resistance of P. aeruginosa, K. pneumoniae, E. coli, A. baumanii in Ukraine Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases Year: 2014 Cystic fibrosis infection with clonal strains of Pseudomonas aeruginosa: current knowledge and future management Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=105 Year: 2006 Predicting the outcome of respiratory Pseudomonas aeruginosa infection in vivo Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring Year: 2017 Effects of direct lung dosing of Tobramycin in a rat chronic infection model using Pseudomonas aeruginosa RP73 Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018